Swiss Parenterals
Ticker > Company >

Swiss Parenterals share price

Swiss Parenterals Ltd.

SECTOR: Pharmaceuticals & Drugs  2590   1   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year30.44%
3 Year82.04%
5 Year44.01%

Profit Growth

1 Year18.32%
3 Year198.62%
5 Year85.92%

ROE%

1 Year30.7%
3 Year31.87%
5 Year22.23%

ROCE %

1 Year42.82%
3 Year42.67%
5 Year30.67%

Debt/Equity

0.1091

Price to Cash Flow

0

Interest Cover Ratio

87.847

CFO/PAT (5 Yr. Avg.)

0.974037116384545

 Strengths

  • The company has shown a good revenue growth of 82.0371909276696% for the Past 3 years.
  • Company has been maintaining healthy ROE of 31.8709960410318% over the past 3 years.
  • Company has been maintaining healthy ROCE of 42.6712682367753% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 87.847.
  • The Company has been maintaining an effective average operating margins of 23.1578842471423% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 20.6144 days.

 Limitations

 Looks like the company does not have any serious limitations.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2023 Mar 2024
Net Sales 48.35 48.29 56.69 223.32 291.29
Total Expenditure 41.59 39.64 42.82 145.82 211.31
Operating Profit 6.76 8.65 13.87 77.5 79.98
Other Income 0.33 0.68 0.71 11.87 27.54
Interest 2.07 1.69 1.19 0.98 1.18
Depreciation 3.92 3.58 3.11 7.79 3.59
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.11 4.06 10.28 80.59 102.74
Tax 0.39 1.43 3.81 21.5 32.82
Net Profit 0.72 2.63 6.46 59.09 69.92
Adjusted EPS (Rs.) 1.3 0 8.77 80.17 125.25

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2015 Mar 2016 Mar 2017 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 1.24 1.64 7.37 7.37 5.58
Total Reserves 17.21 25.43 26.21 264.71 177.82
Borrowings 11.29 5.89 6.15 0 0
Other N/C liabilities 0.12 -0.17 -0.38 4.1 0.73
Current liabilities 29.13 17.33 28.21 63.31 121.17
Total Liabilities 58.98 50.12 67.57 339.49 305.3
Assets
Net Block 23.86 20.89 18.92 46.78 59.11
Capital WIP 0.18 0.32 4.21 1.81 0.21
Intangible WIP 0 0 0 0 0
Investments 0 0 0 15.38 5
Loans & Advances 0.48 0.5 3.08 25.67 32.43
Other N/C Assets 0 0 0.47 76.89 0.18
Current Assets 34.46 28.42 40.89 172.96 208.38
Total Assets 58.98 50.12 67.57 339.49 305.3
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024
Profit from operations 80.59 102.74
Adjustment 1.86 -19.02
Changes in Assets & Liabilities -43.87 54.65
Tax Paid -24.11 -31.27
Operating Cash Flow 14.48 107.1
Investing Cash Flow -9.19 32.12
Financing Cash Flow 10.07 -148.86
Net Cash Flow 15.37 -9.64

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about Swiss Parenterals
X